The Neuro4D conference takes place in Mainz, Germany on May 27-28, 2024.

With a focus on drug discovery for proteopathic neurodegenerative diseases, the meeting brings together experts from discovery companies, service providers and academic innovators in the field of neurodegenerative diseases e.g. Alzheimer’s disease, Parkinson’s disease, FTD and ALS.

At the meeting, Lotta Agholme, Chief Operating Officer at Cellectricon, will present a poster titled:

Characterization of an in vitro neuroinflammation assay platform incorporating human microglia with rodent neurons and astrocytes

If you are interested in learning more about the poster or Cellectricon’s drug discovery services, please reach out to us.

Visit event site